US$ 27.70
are all glp 1 injectable GLP-1 Weight Loss Injections: 10 FAQs, Answered A New Era of Weight
Description
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial

Both Mounjaro and Ozempic are medications (once weekly injections) that work by enhancing the bodys natural hormone responses

A similar trial (STEP-HFpEF DM) has been conducted in individuals with T2D and HFpEF, demonstrating similar beneficial results (94)

Medical weight-loss medication is generally considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, or prediabetes

However, not all of them have been approved as weight loss drugs

Neuropsychopharmacology 42, 23872397
